Eskayef launches anti-migraine medicine
Eskayef Bangladesh Limited, one of the leading pharmaceutical companies of the country, has launched a new drug, TUFNIL® tablet, for treatment of migraine for the first time in Bangladesh, says a press release.TUFNIL is a preparation of tolfenamic acid 200 mg that is highly effective in the symptomatic relief of acute migraine pain. With its distinctive 'dual mode of action', the medicine blocks both cyclooxygenase and lipooxygenase pathways and thus provides better pain relief than conventional drugs do. TUFNIL is well tolerated in patients with asthma or peptic ulcer disease as it also blocks lipooxygenase pathway. The drug is available in box containing 40 tablets throughout the country.
|
|
